The syringes market is projected to grow from USD 26.8 billion in 2025 to USD 63.4 billion by 2035, registering a CAGR of 9.0% during the forecast period. Sales in 2024 reached USD 24.5 billion, indicating a steady demand trajectory.
| Metric | Value |
|---|---|
| Market Size in 2025 | USD 26.8 billion |
| Projected Market Size in 2035 | USD 63.4 billion |
| CAGR (2025 to 2035) | 9.0% |
This growth has been attributed to the increasing prevalence of chronic diseases, such as diabetes and cancer, which require regular administration of injectable medications. The rise in immunization programs and the demand for self-administration of drugs have further propelled the adoption of syringes.
In March 2024, SCHOTT Pharma, a pioneer in pharmaceutical drug containment solutions and delivery systems, announced that it will build the first USA facility to manufacture prefillable polymer syringes required to meet the need for deep-cold storage and transportation of mRNA medications.
The new site will expand the USA supply chain for in-demand syringes that deliver lifesaving injectable medicines, vaccines, and other fields of applications, allowing SCHOTT Pharma to triple its contribution of glass and polymer syringes to the USA market by 2030. “As drug manufacturers develop and expand the use of mRNA, GLP-1, and other biologic therapies that require precise drug stability and storage properties, SCHOTT Pharma will be able to fill those orders quickly and efficiently here in the USA,” said Andreas Reisse, CEO of SCHOTT Pharma. “The impact of this facility will go far beyond local job creation in North Carolina and will relieve stress on the entire pharmaceutical industry supply chain.”
Advanced manufacturing practices have been adopted across syringe production lines to reduce energy intensity and limit industrial waste. Innovations in cyclic olefin polymers and BPA-free formats have addressed long-standing concerns over extractable and leachable.
Regulatory pressures in the EU and North America have pushed manufacturers to adopt ISO-compliant cleanroom systems and eco-efficient sterilization methods. Recyclable packaging components and closed-loop tray solutions have been introduced to support hospitals’ sustainability goals. Companies have invested in digital traceability systems and RFID tagging, especially in vaccine rollout campaigns.
Looking ahead, the Syringes Market is poised for continued growth, driven by the ongoing expansion of various healthcare sectors and the increasing emphasis on sustainable medical solutions. The market's trajectory suggests a steady rise in demand for innovative, eco-friendly syringes that cater to both healthcare providers' preferences and regulatory requirements.
Companies investing in research and development to create durable, cost-effective, and environmentally friendly syringes are expected to gain a competitive edge. The integration of advanced materials and ergonomic designs will likely play a crucial role in shaping the future of the Syringes Market.
The market is segmented based on material, syringe type, capacity, end-use application, and region. By material, the market includes glass syringes, plastic syringes, and stainless steel syringes. In terms of syringe type, the market is categorized into disposable syringes and reusable syringes.
By capacity, the market is segmented into small volume syringes (1 to 10 ml), medium volume syringes (11 to 20 ml), and large volume syringes (above 20 ml). In terms of end-use application, the market comprises hospitals & clinics, diagnostic centers, vaccination programs, veterinary use, and home healthcare. Regionally, the market is analyzed across North America, Latin America, East Asia, South Asia & Pacific, Eastern Europe, Western Europe, Oceania, and the Middle East & Africa.
Plastic syringes have been projected to hold 71% of the syringes market in 2025, driven by their low manufacturing costs, disposability, and widespread adoption across healthcare sectors. Their compatibility with prefilled drug delivery and safety-enhanced designs has been widely recognized by healthcare providers. Standardization in production and compliance with international sterility norms have been ensured through mass-scale production lines. Lightweight and durable plastic grades such as polypropylene have been most frequently utilized.
Disposable plastic syringes have been prioritized by hospitals and vaccination programs to prevent infection transmission and cross-contamination. Regulatory guidelines promoting single-use devices have further elevated demand across developed and emerging economies. Auto-disable features and tamper-evident caps have been incorporated to enhance safety during mass immunization campaigns.
High-volume procurement by public health systems and government tenders has been facilitated by the affordability of plastic syringes. Customization for insulin, vaccine, and oncology drug delivery has been made possible through needle and barrel design variants. Pre-sterilized, individually packed units have been supplied across global distribution networks.
Moreover, minimal disposal concerns relative to glass alternatives have improved logistics and handling safety. Environmental concerns associated with plastic waste have prompted investment in recyclable and biodegradable syringe formats. Innovations in eco-friendly medical-grade plastics have been explored to comply with sustainable healthcare goals. Strategic partnerships between syringe manufacturers and pharmaceutical firms have accelerated adoption of plastic variants for prefilled applications. Plastic syringes are expected to remain dominant due to performance, safety, and accessibility advantages.
Hospitals and clinics have been estimated to account for 60% of the total syringe market share in 2025, due to their pivotal role in primary treatment, emergency care, and surgical procedures. Intravenous drug delivery, anesthetic application, and immunization have all relied heavily on standard and specialty syringes in hospital environments.
Both inpatient and outpatient services have consistently required sterile, reliable syringe solutions. Compliance with health and safety standards has been ensured through centralized procurement practices. Broad application coverage from oncology to pediatrics has positioned hospitals as the key consumers of both conventional and auto-disable syringe types. Integration of syringes into hospital automation systems and electronic medical records has enhanced accuracy and safety during drug administration. Hospitals have also adopted specialized syringe models for precise dosing in intensive care and critical care units.
Procurement contracts with national healthcare authorities and global NGOs have supported large-scale distribution of syringes to hospital networks. Specialized training modules for safe syringe handling have been implemented by hospital administrations globally. Dual-chamber and safety syringes have been increasingly used in operating theatres and infectious disease wards.
Overall, standardized protocols and infection prevention guidelines have driven consistent syringe usage across clinical settings. Ongoing expansion of healthcare infrastructure and investment in hospital systems have continued to elevate syringe demand. Population growth, aging demographics, and the rise of chronic diseases have all increased inpatient admissions and associated injection therapy. Hospitals have been increasingly focused on adopting syringes that enhance efficiency and reduce risk. As a result, this segment is expected to maintain its lead in the syringe market through 2035.
Stringent Regulatory Compliance and Quality Assurance
The syringes market is subject to stringent regulatory scrutiny with respect to safety, sterility, and material quality. Syringe manufacturing is done under strict guidelines laid down by regulatory authorities like the FDA, EMA, WHO, and all of them have rigid requirement for compliance with Good Manufacturing Practices (GMP) and quality certifications.
These rules raise the costs of production and extend the time frame for product approvals, presenting a barrier to market entry for new entrants. For manufacturers, staying compliant while being as cost-effective as possible continues to be a tough challenge to balance.
Environmental Concerns and Waste Management Issues
In recent years the rise in the use of disposable syringes made the generation of medical waste high leading to environmental implications. Treatment of plastic syringes is a major issue as their disposal is categorized as hazardous waste, which leads to regulatory and sustainability issues.
So the manufacturers are investing in biodegradable or recyclable alternatives as over the globe, governments are tightening waste management policies. Nonetheless, development of cost-effective, environmentally friendly syringe solution is still an industry's challenges.
Rising Demand for Safety Syringes
Safety syringes are experiencing an increasing demand due to the growing focus on infection control and needlestick injury prevention. These syringes also have retractable or shielded needles to prevent accidental needle sticks, which lowers rates of health-care-associated infection.
Growing implementation of safety regulations, regulations, and awareness programs by healthcare authorities for reducing the transmission of infections during surgical procedures is projected to create lucrative opportunities for manufacturers to address the need for advanced safety syringes for effective infection prevention.
Technological Advancements in Syringe Design
Syringe technology, such as prefilled syringes and smart syringes those that possess digital monitoring capability represent new innovations that are changing the industry. Prefilled syringes help increase the convenience for patients and the accuracy of drug administration, while smart syringes help in tracking dosage adherence and reducing misuse.
Introduction of digital technologies in syringes to assist chronic disease management and support self-administration, are also anticipated to create new avenues of growth in the market.
It is detrimental for the USA syringes to dominate the syringes market due to the need for vaccination programs, chronic disease management, and the availability of advanced healthcare infrastructure. Key growth drivers are the rising prevalence of diabetes and the growing adoption of self-injection devices.
Such factors, along with strict safety regulations to increase disposable and safety syringes market to grow. The presence of top syringes manufacturing companies followed by the government initiatives to support immunization programs.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 9.2% |
Factors such as increasing vaccination campaigns, growing home healthcare services, and rising awareness regarding infection control measures are driving the growth of the syringes market in the UK Prefilled syringes, as well as safety-engineered syringes, continue to pressure hospitals and clinics.
Needle-free injectors and other advancements in syringe technology are further impacting market trends as well. Furthermore, there are emphasis be put on high safety standards for syringe manufacturing and usage from the regulatory bodies such as the MHRA.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 8.8% |
Growing the geriatric population, increased prevalence of chronic disease like diabetes and cancer, and growing demand for advanced drug delivery systems are propelling the growth of the European Union's syringes market.
Germany, France, and Italy are prominent countries in this region. Significantly, the movement towards sustainable, eco-friendly medical devices, like biodegradable syringes, is influencing market dynamics. The significant government investment in healthcare infrastructure and increased efforts for the reduction of needle-stick injuries using safety syringes reinforce market growth.
| Country | CAGR (2025 to 2035) |
|---|---|
| European Union (EU) | 9% |
Japan is witnessing growth in syringes market due to the demographic factor of ageing population, high healthcare expenditure and greater needs for sophisticated healthcare technologies. The use of prefilled syringes for biologics and vaccines is increasing, driven by innovative drug delivery solutions receiving regulatory approval.
Market growth is also stimulated by Japan's strong pharmaceutical industry and a growing trend towards self-administered injections. Needle safety innovations, including retractable needles and ultra-thin syringes are also on the rise in the market.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 9.3% |
The syringe market in South Korea is growing as a result of the rapid expansion of its biotechnology and pharmaceutical industries. The key market drivers are the increasing prevalence of chronic diseases and the country’s growing emphasis on immunization programs.
The rising prevalence of undesired scenarios from syringes such as Jitters and needle stick injuries is propelling the demand for new designs of syringes such as auto-disable syringes and insulin pens. The other factors driving market growth are government efforts to make healthcare more accessible and to raise safety standards for medical devices.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 9.1% |
The demand for syringes is consistently growing owing to an increase in the number of vaccinations, an increase in chronic incidence, and advancements in safety available in syringe technology. The progressive use of disposable and auto-disable syringes is currently on the rise, fueled by healthcare regulations that are increasingly becoming stringent, focusing on infection control and patient safety.
They are highly focusing on implementing product innovations with more manufacturing capacity and adhering to strict medical device regulations to achieve this. Aid in the Market Dynamics with the Help of Technological Advancements in pre-filled syringes and smart drug delivery systems.
The overall market size for syringes market was USD 26.8 billion in 2025.
The syringes market expected to reach USD 63.4 billion in 2035.
Rising prevalence of chronic diseases, expanding vaccination programs, increasing demand for safety syringes, technological advancements, and growing healthcare infrastructure will drive the syringes market demand.
The top 5 countries which drives the development of syringes market are USA, UK, Europe Union, Japan and South Korea.
Plastic syringes segment driving market growth to command significant share over the assessment period.
Explore Similar Insights
Syringes Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
